학술논문

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
Document Type
Article
Source
In Journal of Thoracic Oncology September 2021 16(9):1501-1511
Subject
Language
ISSN
1556-0864